An innovative new medical instrumentation and biotechnology company known as Daxor just published some exciting new data for their flagship technology, the BVA-100 blood volume analyzer.

A cell-by-cell search for cardiac stem cells has come up empty, suggesting that previous studies hinting at the existence of cardiac stem cells were mistaken.

Biocartis announced it has entered into an agreement with AstraZeneca.

Agilent technologies has announced a new expansion of its Little Island facility in cork, Ireland.

Mesa Biotech recently said that the US Food and Drug Administration has cleared and CLIA-waived the company's Accula RSV respiratory syncytial virus test for diagnostic use in both children and adults.

Novacyt announced recently that its molecular testing division, Primerdesign, has inked an exclusive supply agreement with Genesis Diagnostics.

Stilla Technologies announced recently that it has completed a €16 million ($18.3 million) Series A financing round led by Illumina Ventures.

Bionano Genomics reported a 3 percent increase in third-quarter revenues after the market close recently.

PerkinElmer Genomics has chosen BioDiscovery's NxClinical software for genomic data analysis for its services, BioDiscovery announced recently.

WuXi NextCode said today that it has closed a $200 million Series C financing round.

LGC announced today that it has acquired SeraCare Life Sciences, a provider of quality control materials for the infectious disease testing and next-generation sequencing markets.

Stilla Technologies announced today that it has completed a €16 million ($18.3 million) Series A financing round led by Illumina Ventures.

Agilent Technologies reported after the close of the market on Monday that its fourth quarter revenues grew 9 percent year over year.

The global genotyping market is projected to reach USD 31.9 billion by 2023 from USD 11.8 billion in 2018, at a CAGR of 22.0%.

BioM¨¦rieux, the international leader in in vitro diagnostics, today announced the acquisition of a controlling stake in Suzhou Hybiome Biomedical Engineering Co. Ltd.